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Objective: To investigate whether increased knee joint loading due to improved ambulatory function and
walking speed following weight loss achieved over 16 weeks accelerates symptomatic and structural
disease progression over a subsequent 1 year weight maintenance period in an obese population with
knee osteoarthritis (OA).
Methods: Data from a prospective study of weight loss in obese patients with knee OA (the CARtilage in
obese knee OsteoarThritis (CAROT) study) were used to determine changes in knee joint compressive
loadings (model estimated) during walking after a successful 16 week weight loss intervention. The
participants were divided into ‘Unloaders’ (participants that reduced joint loads) and ‘Loaders’ (partic-
ipants that increased joint loads). The primary symptomatic outcome was changes in knee symptoms,
measured with the Knee injury and Osteoarthritis Outcome Score (KOOS) questionnaire, during a sub-
sequent 52 weeks weight maintenance period. The primary structural outcome was changes in tibio-
femoral cartilage loss assessed semi-quantitatively (Boston Leeds Knee Osteoarthritis Score (BLOKS) from
MRI after the 52 weight maintenance period.
Results: 157 participants (82% of the CAROT cohort) with medial and/or lateral knee OAwere classiﬁed as
Unloaders (n ¼ 100) or Loaders (n ¼ 57). The groups showed similar signiﬁcant changes in symptoms
(group difference: 2.4 KOOS points [95% CI 6.8:1.9]) and cartilage loss (group difference: 0.06 BLOKS
points [95% CI 0.22:0.11) after 1 year, with no statistically signiﬁcant differences between Loaders and
Unloaders.
Conclusion: For obese patients undergoing a signiﬁcant weight loss, increased knee joint loading for 1
year was not associated with accelerated symptomatic and structural disease progression compared to a
similar weight loss group that had reduced ambulatory compressive knee joint loads.
Clinicaltrials.gov: NCT00655941.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.: M. Henriksen, The Parker
rg, Ndr. Fasanvej 57, DK-2000
s Research Society International. PIntroduction
Knee joint loading is believed to be implicated in the patho-
genesis of knee osteoarthritis (OA)1. Dynamic loading of the knee
during walking depends primarily on acceleration and deceleration
of the body mass, muscle contractions, walking speed resulting in
tibiofemoral compression forces. Cross-sectional studies associateublished by Elsevier Ltd. All rights reserved.
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tibiofemoral OA2e4, subchondral bone density5, presence of bone
marrow lesions (BML)6, meniscal extrusion7, and cartilage defects8,
and more importantly, indicated that higher dynamic loading
during walking predicts radiographic disease progression9,10. These
studies underlie the rationale for reducing dynamic knee loads
during walking to potentially delay or stop structural deterioration.
Obesity is a major risk factor for development and progression of
knee OA11,12, and is believed to act mainly through high mechanical
loads13, although systemic effects are also involved14. Accordingly,
weight losse a treatment designed to reduce loadinge is advocated
in obese and overweight personswith kneeOA15,16. A recent study of
weight loss in patients with knee OA showed that an average of 13 %
weight loss over 16 weeks was associated with a 7% reduction in
tibiofemoral compression forces duringwalking17. This has also been
shown in long-term (18 months) studies18,19, and 1 kg weight loss is
on average associated with 2e4 kg reduction in tibiofemoral joint
compression forces during walking17,18.
Weight loss yields positive outcomes on pain, disability, walking
speed, and ambulatory knee function15,17,20. Yet, reduced pain,
higher walking speed, and improved ambulatory knee function are
associated with increased joint loads21e26. Thus, while successful
weight loss on average may reduce joint compression, it also raises
concern of increased loading through improved function. Although
increased joint loads are thought to be detrimental and accelerate
structural changes, no data exist on such potentially undesirable
effects of successful treatments. The results of our recent weight
loss study in knee OA17 offered the opportunity to address this
concern, since approximately 1/3 of the participants responded to a
signiﬁcant weight loss by increasing walking speed and improving
ambulatory knee function in a manner that increased knee joint
loading during walking. Our previous cohort study17 reported im-
mediate biomechanical changes over the 16 week weight loss
program, whereas the present study focus on changes during the
subsequent 1 year period.
The objective of this study was to investigate whether increased
loading of the knee joint (following successful weight loss) caused
accelerated symptomatic and structural disease progression over 1
year compared to a group that reduced loading. We hypothesized
that increased tibiofemoral joint compression forces duringwalking
accelerate structural and symptomatic disease progression.
Patients & methods
Participants and weight loss program
We used data from the weight loss study in knee OA - the
“CAROT study” (inﬂuence of weight loss or exercise on CARtilage in
obese knee OsteoarThritis patients). Eligibility criteria for the
CAROT study were age above 50 years, clinical knee OA conﬁrmed
by radiography (osteophytes and/or joint space narrowing assessed
by a radiologist), and a BMI>30 kg/m2. 192 knee OA patients were
included and given an initial 16 week intensive diet intervention,
aiming at weight loss>10%17,20,27. The dietary program consisted of
a low-energy-diet plus meal replacements (CambridgeWeight Plan
UK) and nutritional education as described elsewhere20,27.
Following the weight loss program the participants were
enrolled in a 1-year maintenance program with random assign-
ment to (1) dietary consultancy, (2) exercise therapy, or (3) a no
intervention control group. Thus the total study duration was 68
weeks (16 weeks weight loss þ 52 weeks maintenance). The par-
ticipant’s most symptomatic knee at inclusion was designated as
target knee for assessments throughout the study. The CAROT study
was approved by the local ethical committee and written informed
consent was obtained from each participant.Study design overview
In the present study data from the biomechanics sub-cohort
(82% of the CAROT cohort) were analyzed, consisting of partici-
pants eligible for gait analysis at inclusion (palpation of anatomical
landmarks possible and able to walk independently without
walking aid) with completed recordings of three-dimensional gait
analysis before and after the weight loss program17. The change in
peak knee compression forces after the 16 week weight loss
intervention was used for group allocation of the participants into
two exposure categories e ‘Unloaders’ and ‘Loaders’: Unloaders
were deﬁned as participants that decreased the peak compression
force after the weight loss; Loaders were participants that
increased the peak compression force. Any change, disregarding
magnitude, resulted in ‘group allocation’. We compared the
changes in symptomatic, structural, and biomechanical variables
(see below) from week 16e68 (maintenance period).
Outcome measures
Major outcomes
The co-primary outcomes of this secondary analysis were
changes in patient-reported symptoms and tibiofemoral cartilage
loss assessed from magnetic resonance imaging (MRI) using the
cartilage1 score of the Boston Leeds Knee Osteoarthritis Score
(BLOKS)28. Changes were calculated by subtracting the week 68
value (1 year follow-up) from the week 16 value (post weight loss).
All assessors were blinded to the case status.
Symptomatic assessment. Symptoms were assessed using the Knee
Osteoarthritis Outcome Score (KOOS)29 e quantiﬁed as the average
of four of the ﬁve KOOS subscales (Pain; Symptoms; Function in
daily living; and Knee related quality of life) named KOOS4. The
scores range from 0 (worst) to 100 (best).
MRI acquisition and reading. On a 1.5 T whole body scanner (Philips
Intera, software release 12.1.5.0) all participants had MRI of their
target knee using a ﬂex coil. The entire protocol is described else-
where30 and included sagittal 3D FLASH gradient-echo (recon-
structed to 3 mm slices, TR 21 ms, TE 8.4 ms, FA 20, FOV
160  160 mm, matrix 512  512), sagittal non fat sat DUAL turbo
spin echo proton density and T2-weighted sequence (4 mm slices,
TR 2531.3 ms, TE 15/100, FOV 170  170 matrix 256  256), coronal
T1 turbo spin echo (3 mm slices, TR 500 ms, TE 17 ms, FOV
150  150 mm, matrix 512  512) and STIR (3 mm slice, TR 1797, TI
9 ms, TE 55 ms, FOV 150  150 mm, matrix 512 512). We used the
sagittal FLASH and proton/T2-weighted DUAL echo sequences for
cartilage loss scoring. Because is difﬁcult to separate ﬂuid and
cartilage on the FLASH sequence, minor cartilage losses are difﬁcult
to detect reliably. We partly compensated for this by using the
corresponding sagittal dual spin echo sequence to verify the score
and to adjust for potential joint ﬂuid between the cartilage layers.
We used the coronal T1 and STIR images for BML scoring.
Cartilage loss was assessed in the medial and lateral weight
bearing femoral and tibial regions according to the cartilage1 score
in BLOKS28 and graded semi-quantitatively on a 0e3 scale based on
regional involvement of any cartilage loss (including partial and full
thickness loss): 0: None; 1: <10%; 2: 10e75%; 3: >75% of region
cartilage surface area. The maximum score across all four regions
deﬁned the global tibiofemoral value used as primary outcome. The
maximum score across the medial tibial and medial femoral re-
gions deﬁned the medial score, and likewise for the lateral regions.
HG performed all BLOKS assessments; intra- and inter-reader
reliability were assessed by HG and MB (Kappa coefﬁcients: carti-
lage: inter-reader: 0.59; intra-reader: 0.81. BML: inter-reader: 0.65;
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images are given in Fig. 1.
Minor outcomes
Secondary symptomatic outcomes were changes from week
16e68 in each of the ﬁve KOOS subscales.
Secondary structural outcomewas changes fromweek 16e68 in
BMLs. BMLs appear as ill-deﬁned signal intensity changes in the
subchondral bone. BMLs were assessed semi-quantitatively in the
medial and lateral weight bearing femoral and tibial regions ac-
cording to the BLOKS28. They were graded on a 0e3 scale based on
the regional involvement: 0: None; 1:<10%; 2: 10e25%; 3:>25% of
the region. The maximum score across all four regions deﬁned the
global maximal tibiofemoral value. The maximum score across the
medial tibial and medial femoral regions deﬁned the medial BML
score, and likewise for the lateral regions.
Objective physical function. Six-minute walking distance was
measured using the 6-min walk test32, performed in-doors on a
pre-deﬁned 100 m route. The participants walked the route as
many times as possible in 6 min at maximum speed. Distance
covered in meters was the result of the test.
Explanatory variables
Walking biomechanics. Walking biomechanics were acquired at
week 0, 16, and 68 by three-dimensional gait analysis using a six
camera 100 Hz motion analysis system (MX13, Vicon, Oxford, UK)
synchronizedwith two force platforms operating at 1000 Hz (AMTI,
Watertown, MA, USA). The details of the gait analysis protocol are
described elsewhere17. The participants walked unshod on a 10 m
walkway at self-selected walking speeds determined during prac-
tice walks. Once self-selected walking speed was determined, six
acceptable walking trials were recorded, deﬁned as 0.1 km/h of
the self-selected walking speed.
The analyses focused on the stance phase of the gait cycle.
Internal inter-segmental net resultant forces and moments were
calculated using the Plug-In-Gait (Vicon, Oxford, UK). Peaks in
the knee joint moments were extracted, averaged across the six
trials, and reported in Newton-meters (Nm). Peak knee joint
compressive forces (reported in Newtons (N)) were estimated
using a statically determinate muscle model33. In brief, the kneeFig. 1. Representative images from the 3D reconstructed 2 mm sagittal 3D FLASH gradient-e
and T2-weighted (right) sequences in the medial part of the medial tibiofemoral joint. The F
bearing region of the femur (between the vertical arrows) corresponding to a grade 2 cartilag
of the limited contrast between ﬂuid and cartilage in the FLASH sequence image, the scor
images indicating ﬂuid between the femoral and tibial cartilage (horizontal arrows). Note
effusion in the medial recess and posterior to the meniscus.compression force was estimated as the vector sum of (1) the
inter-segmental reaction forces resolved along the long axis of
the tibia, (2) the compression components of the assumed active
muscle group forces and (3) the axial component of the cruciate
ligament forces. The included muscles were the hamstrings,
gastrocnemius and quadriceps muscles. The muscle forces were
estimated by dividing the net sagittal plane joint moments with
the muscle moment arms derived from third-order polynomials
based on the sagittal knee joint angle34. The axial cruciate lig-
ament forces were estimated assuming that the cruciates only
resist antero-posterior shear calculated as the sum of the
antero-posterior knee joint reaction force and the antero-
posterior component of the muscle forces acting over the
knee. Based on 30 individuals assessed twice separated by one
week done prior to the study, intra-class correlation coefﬁcient
for the estimation of peak compression force in our lab is 0.91
(95% CI: 0.83e0.96), similar to previous reports on obese knee
OA patients35.
Ambulatory knee function assessment. Changes from week 0 (pre-
weight loss) to week 16 in self-selected walking speed (during gait
analyses) and internal knee extensor moments were used as in-
dicators of changes in ambulatory knee function, with increases
indicating improvement36.
Statistical methods
To explore what factors that explain the changes in compression
forces in each group, group-wise multiple regression analyses were
done with weight loss, changes in internal knee extensor moment,
and walking speed as predictors.
From an epidemiological perspective this study was designed as
a nested prospective cohort with biomechanically ‘Exposed’ and
‘Unexposed’ individuals37. The groups can differ in measured or
unmeasured characteristics because of group assignment (Un-
loaders vs Loaders)38.
For the purpose of transparent reporting, we present esti-
mates from both basic and adjusted statistical models for the
primary outcomes37. Basic analyses: General linear models were
used to compare changes from week 16 to week 68 between
groups with a factor for group (Unloaders vs Loaders) includingcho (left), sagittal non fat sat DUAL turbo spin echo proton density weighted (middle)
LASH image indicates reduced cartilage thickness (cartilage loss) in the anterior weight
e loss (deﬁned as any cartilage loss in 10e75% of region cartilage surface area). Because
e was conﬁrmed from the proton density weighted (middle) and T2-weighted (right)
the anterior osteophyte, bone marrow changes in the anterior tibia, and a moderate
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as covariates. Adjusted analysis: We repeated the analysis
further including age, sex, week 16 BMI, and the randomization
code in the underlying RCT (Diet, Exercise and Control) as
covariates. All minor and explanatory outcomes were analyzed
according to the same algorithm, however only the adjusted
results are presented.
To account for missing data we did multiple imputation of
missing measurements, assuming data were missing at random
and followed a multivariate normal distribution. As the results
were unchanged we present the imputed case analyses. All ana-
lyses were done applying SAS software (v. 9.2; SAS Institute, NC,
USA). Statistical signiﬁcance was accepted at P < 0.05.
Sensitivity analyses were performed by cross-sectional corre-
lations (Spearman) between knee compression force and the pri-
mary outcomes at week 16 and 68. Furthermore, we redeﬁned
Loaders and Unloaders based on the changes in knee compression
force from week 16e68 (Unloaders16e68 and Loaders16e68) and
comparing the changes in outcomes between those groups using
the same statistical models as above.Results
Of the 192 CAROT participants, 177 (92%) were eligible for the
biomechanics sub-cohort (Fig. 2). Of those, 157 had complete
walking biomechanics records at week 0 and 16 and constituted the
current sample. Of these, 100 (64%) participants were deﬁned asFig. 2. Study proﬁle illustrating the ﬂo“Unloaders” and 57 (36%) as “Loaders”. The group allocations in the
underlying RCT (Diet, Exercise and Control) were equally distrib-
uted in the two groups (c2 ¼ 3.22; df ¼ 2; P ¼ 0.89).
One year after the weight loss (i.e., at week 68), there were 144
participants (92%) remaining in the biomechanics sub-cohort, i.e.,
13 participants lost to follow-up (Fig. 2). These were distributed
with 7 (7%) in the Unloader group and 6 (11%) in the Loader group.
The characteristics of the lost participants were not different from
those completing the study (data not shown).Changes from week 0e16
At week 0 the Unloaders walked faster and with higher knee
compression force than the Loaders (Appendix 1). After the weight
loss the Unloaders on average reduced peak knee compression
force by 509 N [95% CI: 588:429] while it increased by 425 N
[95% CI: 322:528] among Loaders.
Among the Unloaders the ambulatory knee function was not
improved from week 0 to week 16, seen as no statistically signiﬁ-
cant change in walking speed and a reduction in the knee extensor
moment (Appendix 1). The explanatory multiple regression
showed that reduced compression force was predicted by re-
ductions in the knee extensor moment and body mass (R2 ¼ 0.46).
In contrast, the ambulatory knee functionwas improved among the
Loaders, seen as increases in walking speed and internal knee
extensor moment (Appendix 1). Explanatory multiple regression
showed that only the increase in knee extensor moment predictedw of patients through the study.
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the week 0, 16, and 68 data are available in Appendix 1.Week 16
At week 16 (after weight loss) the Loaders walked with signif-
icantly higher peak compression forces and peak internal knee
extensor and ﬂexor moments compared to the Loaders (Table I).
There were no other statistically signiﬁcant differences between
the Unloaders and Loaders at week 16 (Table I).Outcomes at week 68
The change over 1 year from week 16 in KOOS4 did not differ
signiﬁcantly between groups (Table II). Similarly, the group differ-
ence in the change in global tibiofemoral cartilage loss score was
not statistically signiﬁcant (Table II). The results did not change in
the adjusted analyses.
The changes in secondary outcomes at the week 68 are pre-
sented in Table II. The results did not support statistically signiﬁ-
cant differences in the changes from week 16 between UnloadersTable I
Variables at week 16 according to categorized biomechanical response to a 16 week wei
Mean (SD)*
Unloaders (n ¼ 100)
Demographics
Body mass, kg 87.7 (12.6)
Height, m 1.66 (0.08)
BMI, kg/m2 31.7 (3.9)
Symptom duration, y 8.9 (9.1)
Age, y 62.5 (6.3)
Gender, number of females (%) 83 (83%)
Alignment, degrees 5.7 (4.9)
Kellgren/Lawrence, 0e4
0, n(%) 0 (0%)
1, n(%) 8 (8%)
2, n(%) 34 (34%)
3, n(%) 42 (42%)
4, n(%) 16 (16%)
Primary outcomes
Global max tibiofemoral cartilage loss, 0e3 2.0 (0.9)
KOOS4, 0e100 66.6 (16.4)
Secondary outcomes
MRI
Medial max tibiofemoral cartilage loss, 0e3 1.8 (1.0)
Lateral max tibiofemoral cartilage loss, 0e3 1.3 (0.7)
Global max tibiofemoral BML, 0e3 1.5 (1.0)
Medial max tibiofemoral BML, 0e3 1.1 (1.0)
Lateral max tibiofemoral BML, 0e3 0.3 (0.6)
Patient reported
KOOS pain, 0e100 69.5 (18.4)
KOOS symptoms, 0e100 72.9 (18.2)
KOOS activities of daily living, 0e100 73.9 (17.3)
KOOS sports and recreation, 0e100 33.0 (26.4)
KOOS quality of life, 0e100 50.1 (19.0)
Walking biomechanics
Peak joint compression, N 2,378 (741)
Walking speed, m/s 1.21 (0.17)
Peak knee extensor moment, Nm 46.8 (23.7)
Peak knee ﬂexor moment, Nm 13.2 (17.0)
First peak knee abduction moment, Nm 43.0 (17.7)
Second peak knee abduction moment, Nm 40.0 (17.1)
First peak knee rotator moment, Nm 0.6 (1.0)
Second peak knee rotator moment, Nm 14.2 (5.5)
Objective physical function
6 MWD, m 485.6 (74.5)
* Arithmetic mean.
y Frequencies tested using chi squared.and Loaders, except for the second peak abductor moment that
increased more among the Loaders (Table II). Both groups
increased the peak tibiofemoral compression force during the
maintenance period; the Loaders more so than the Unloaders
(P ¼ 0.06; Table II).
Sensitivity analyses
The cross-sectional correlations between the peak compression
force and cartilage loss scores at week 16 and 68 were not signiﬁ-
cant (r ¼ 0.03; P ¼ 0.696 and r ¼ 0.09; P ¼ 0.277, respectively).
Similar results were found regarding the KOOS4 (week16:r ¼ 0.08;
P ¼ 0.35; week 68:r ¼ 0.05; P ¼ 0.53). When creating and
comparing groups based on changes in joint compression from
week 16e68, there were no statistically signiﬁcant group differ-
ences in the changes in the primary and secondary outcomes
(Appendix 2).Discussion
This study showed that improvements in ambulatory knee
function yielding increased peak knee joint compression forcesght loss intervention
Mean* difference (95% CI)
(UnloaderseLoaders)
P-value
Loaders (n ¼ 57)
89.3 (14.3) 1.6 (6.0; 2.7) 0.46
1.67 (0.08) 0.00 (0.03; 0.03) 0.88
32.2 (4.3) 0.04 (1.8; 0.9) 0.51
9.2 (8.7) 0.2 (3.1; 2.7) 0.89
63.5 (6.5) 1.1 (3.1; 1.0) 0.32
46 (81%) n/a 0.72y
5.9 (4.5) 0.2 (1.8; 1.4) 0.79
0 (0%) n/a 0.19y
8 (14%) n/a
25 (44%) n/a
15 (26%) n/a
9 (16%) n/a
1.8 (0.9) 0.1 (0.1; 0.4) 0.34
64.3 (17.1) 2.3 (3.2; 7.7) 0.41
1.6 (1.0) 0.2 (0.1; 0.5) 0.19
1.2 (0.6) 0.1 (0.1; 0.3) 0.32
1.4 (0.9) 0.2 (0.1; 0.5) 0.26
1.0 (0.9) 0.1 (0.2; 0.4) 0.52
0.4 (0.6) 0.0 (0.2; 0.2) 0.71
68.7 (19.3) 0.8 (5.3; 7.0) 0.79
69.1 (20.0) 3.8 (2.4; 9.9) 0.23
72.4 (19.0) 1.4 (4.4; 7.3) 0.63
31.8 (24.3) 1.2 (7.2; 9.7) 0.77
47.0 (16.8) 3.1 (2.9; 9.1) 0.31
2,647 (602) 269 (484; 54) 0.02
1.23 (0.20) 0.02 (0.08; 0.04) 0.50
54.6 (18.0) 7.9 (14.5; 1.2) 0.02
7.9 (16.5) 5.4 (10.9; 0.1) 0.06
39.5 (15.7) 3.6 (2.0; 9.1) 0.21
39.2 (16.8) 0.8 (4.8; 6.4) 0.77
0.5 (1.0) 0.1 (0.4; 0.3) 0.76
14.0 (5.7) 0.2 (1.6; 2.1) 0.79
496.4 (70.6) 10.7 (34.7; 13.3) 0.38
Table II
Changes fromweek 16 to week 68 in primary and secondary outcomes (i.e., after the 1-year maintenance period). Data are presented for patients grouped according to their
biomechanical response to the 16 week weight loss program (Unloaders vs Loaders)
Least squares means (SE) Least squares means difference (95% CI)
(UnloaderseLoaders)
P
Unloaders (n ¼ 100) Loaders (n ¼ 57)
Primary outcomes
Patient reported
DKOOS4, 0e100* 3.6 (1.2) 2.3 (1.7) 1.3 (5.6; 3.0) 0.55
DKOOS4, 0e100y 3.8 (1.5) 1.4 (1.8) 2.4 (6.8; 1.9) 0.27
MRI
DGlobal max tibiofemoral cartilage loss, 0e3y 0.01 (0.01) 0.07 (0.01) 0.06 (0.22; 0.10) 0.47
DGlobal max tibiofemoral cartilage loss, 0e3* 0.06 (0.06) 0.00 (0.07) 0.06 (0.22; 0.11) 0.49
Secondary outcomesy
Demographics
DBody mass, kgy 4.9 (0.9) 6.3 (1.2) 1.4 (3.9; 1.1) 0.28
DBMI, kg/m2y 1.5 (0.3) 2.0 (0.4) 0.5 (1.4; 0.4) 0.28
Patient reported
DKOOS pain, 0e100y 3.4 (1.8) 0.8 (2.2) 2.5 (7.8; 2.7) 0.34
DKOOS symptoms, 0e100y 3.3 (1.7) 0.9 (2.1) 2.3 (7.3; 2.7) 0.36
DKOOS activities of daily living, 0e100y 3.3 (1.7) 3.1 (2.1) 0.2 (5.3; 4.9) 0.95
DKOOS sports and recreation, 0e100y 6.5 (2.5) 3.8 (3.0) 2.7 (10.0; 4.6) 0.46
DKOOS quality of life, 0e100y 5.6 (2.0) 0.9 (2.4) 4.7 (10.4; 1.0) 0.11
MRI
DMedial max tibiofemoral cartilage loss, 0e3y 0.02 (0.05) 0.12 (0.07) 0.10 (0.26; 0.06) 0.23
DLateral max tibiofemoral cartilage loss, 0e3y 0.01 (0.05) 0.05 (0.06) 0.04 (0.10; 0.19) 0.56
DGlobal max tibiofemoral BML, 0e3y 0.12 (0.08) 0.06 (0.10) 0.06 (0.30; 0.19) 0.65
DMedial max tibiofemoral BML, 0e3y 0.04 (0.06) 0.00 (0.08) 0.04 (0.14; 0.23) 0.66
DLateral max tibiofemoral BML, 0e3y 0.06 (0.05) 0.06 (0.06) 0.12 (0.04; 0.27) 0.14
Walking biomechanics
DPeak joint compression, Ny 175.1 (67.8) 415.4 (96.3) 240.4 (491.1; 10.3) 0.06
DWalking speed, m/sy 0.01 (0.01) 0.00 (0.02) 0.01 (0.05; 0.03) 0.61
DPeak knee extensor moment, Nmy 4.3 (2.2) 10.5 (2.7) 6.2 (13.6; 1.1) 0.10
DPeak knee ﬂexor moment, Nmy 7.3 (1.6) 2.3 (1.9) 5.0 (0.4; 9.7) 0.03
DFirst peak KAM, Nmy 0.1 (1.1) 0.2 (1.3) 0.3 (3.4; 2.8) 0.84
DSecond peak KAM, Nmy 4.3 (1.0) 7.6 (1.2) 3.3 (6.1; 0.4) 0.03
DFirst peak knee rotator moment, Nmy 0.4 (0.2) 0.5 (0.2) 0.0 (0.4; 0.5) 0.91
DSecond peak knee rotator moment, Nmy 1.1 (0.4) 1.3 (0.4) 0.2 (1.3; 0.9) 0.70
Objective physical function
D6 MWD, my 4.0 (10.9) 20.1 (13.5) 24.0 (56.3; 8.2) 0.14
* Basic analysis: adjusted for week 16 value and pre-weight loss peak compression force.
y Adjusted analysis: adjusted for week 16 value, pre-weight loss peak compression force, age, gender, week 16 BMI, and randomization in the underlying RCT.
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nor improvement to structural or symptomatic disease progression
1 year later compared to participants that decreased peak knee
joint compression forces.
The Unloaders’ reductions in joint compression force were
related to theweight lossmagnitude and reduction in knee extensor
moments suggesting reduced demands to the quadriceps e linked
to lower body mass. As muscles are signiﬁcant contributors to joint
compression forces39, the biomechanical response to weight loss
among the Unloaders corresponds with the hypothesis of a rela-
tionship between weight and joint loads. In contrast, the Loaders
increased joint compression signiﬁcantly - despite signiﬁcant
weight loss emainly caused by increased knee extensor moments,
representing improved ambulatory knee function with enhanced
employment of the quadriceps. Increasing knee extensor moments
and walking speed typically follow each other e as in the present
study. This shows that opposite responses in ambulatorymechanics
can emerge froma treatmentwith a hypothesizedmono-directional
mechanism of action: Reducing joint loads. These opposite re-
sponses could indicate regression to the mean. While this is a true
concern, we adjusted our analyses for the pre-weight loss value,
which is known to be an effective way of handling potential
regression to the mean40.
Our ﬁndings are unexpected, as the Loaders were hypothesized
to have larger structural and symptomatic deterioration. The
present study does not provide insights into the underlyingbiological mechanisms, but there are some indications from
existing literature that may provide hypothetical explanations. In
support of our results, an animal study indicated that increased
joint loading insufﬁciently explain the obesityeOA relationship41.
Knee joint compressive forces during running range between 8
and 14 times body weight42, yet the relationship between running
and OA is unclear. In fact, moderate running has been indicated as
chondroprotective43. Furthermore, weight bearing exercises may
be beneﬁcial for cartilage quality in individuals at risk of knee
OA44.
The peak knee abductor moment (KAM) is often used as proxy
for dynamic loading of the medial compartment. Yet medial loads
are mediated or enhanced by the knee extensor moment, because
the combination of the KAM and the extensor moment is a better
predictor of peak medial loads than the KAM alone45. The overall
compression force is a composite and generic measure for loading,
yet relates not only to themedial compartment. Signiﬁcant changes
in overall compression force indicate increasing medial and lateral
compartment loads thus making it applicable for all tibiofemoral
OA.
While dynamic loading of the knee joint is widely accepted as
a risk factor for structural disease progression9,10 the current
evidence does not support dynamic loading modiﬁcations as
effective to prevent structural progression over a 1-year follow-
up46. Our results showed that increased loading did not yield
detectable structural disease progression when compared to a
M. Henriksen et al. / Osteoarthritis and Cartilage 21 (2013) 1865e1875 1871group with reduced joint loading. Further, the Loaders had
higher loadings at week 16 and 68 (Table I&II). This is in contrast
to studies that indicate high dynamic loading as a risk factor for
progression9,10. However, these studies are based on cross-
sectional data, whereas the present study assessed longitudinal
changes. Further, these studies had either a longer follow-up9 or
used a dynamic load measure that can increase with reduced
walking speed (KAM impulse25) and it is uncertain if the results
were related to increased load or reduced walking speed in pa-
tients with more severe OA10. Thus, the selection of the load
measure and the length of follow-up are important in the
interpretation of these data.
Many parameters in ambulatory biomechanics are intimately
coupled and their role in knee OAmay interact with other factors. It
is very likely that the effects of joint compression modiﬁcations are
confounded by other factors (including phenotypic, hormonal,
biomechanical etc.) that are unaltered by load modifying in-
terventions. The relevant modiﬁable factors associated with
changes in knee biomechanics e and their interactions e are yet to
be identiﬁed.
This is the ﬁrst study to assess the effects of increased joint loads
on symptomatic and structural disease progression in knee OA, and
therefore we cannot compare our results directly to other studies.
Pain relief has been shown to increase joint loadings during
walking21e23,47, leading to speculations about accelerated joint
destruction. Also, exercise improves pain and physical disability48.
According to the prevailing theory about increased joint loading,
improvements in pain and function should lead to accelerated
disease progression. However, no long-term follow-up studies on
structural deterioration associated with pain relief exist in spite of
extensive research on pharmacological pain relief and exercise for
knee OA. In this study both groups had similar pain reductions and
similar structural changes over 1 year in spite of substantial dif-
ferences in the change in load from pre-weight loss to the ﬁnal
assessment.
This study has strengths and limitations. An important strength
is the blinded nature of our results. Both participants and study
staff were blinded to the “group allocation” as they were not aware
of the biomechanical response at anytime during the study. This is
an advantage with respect to other studies of mechanical in-
terventions that are very difﬁcult to blind effectively. A further
strength is the large change in joint loads in both groups (Un-
loaders: 18% and Loaders: þ19%) although the within-group dis-
persions also were quite large. No data exist on the magnitude of
clinically relevant load changes, and in spite of large changes,
identiﬁcation of magnitude and direction of joint load changes that
yield clinically relevant changes in symptoms and structural dis-
ease parameters was not possible. The changes are larger than
previous changes after weight loss18,19, which might have been
inﬂuenced by a similar Unloader/Loader response regressing the
average change.
A limitation is the applied knee model that is subject to as-
sumptions that might inﬂuence the results. Importantly, it does not
allow co-activation between knee extensors and ﬂexors, whichmay
underestimate the magnitude of the knee compression force.
Further, the patellofemoral joint is not included, but we did not
assess structural changes in that region. Yet, it is likely that similar
biomechanical responses would occur due to the close association
between patellofemoral compression and knee extensor employ-
ment. There are many other ways to express joint loads and we
cannot rule out that changes in other indices of joint loads may
have pathomechanical signiﬁcance in knee OA. It may even be
speculated that there may be “good” and “bad” loading, but the
characteristics and causal mechanisms behind such qualitative la-
bels remain to be illuminated.The lack of group differences could be a reﬂection that the
study is underpowered. However, the group sizes and observed
variations allow for detections of mean differences of eight
KOOS4 points and 0.45 cartilage loss score points with a statis-
tical power above 80%, corresponding to effect sizes of 0.48 and
0.50, respectively. These differences would be both clinically
relevant and plausible.
Because of the limited contrast between ﬂuid and cartilage us-
ing the Flash MRI sequence, smaller cartilage losses are easily
missed, which is a limitation. In an attempt to partially compensate
for this we compared the Flash and dual spin echo images to verify
cartilage lesion scores. Also, the semi quantitative assessment
(BLOKS) of structural changes might not be sensitive to changes
over 1 year, as it has only been tested after 2 years follow-up49. Nor
will detailed within-grade structural changes be detected using this
method. Furthermore, ﬂuctuations in walking biomechanics over 1
year may blur the effects on symptoms and structures. Moreover,
changes in habitual physical activity may affect structural pro-
gression50, but unfortunately we did not assess physical activity.
However, our results are robust to different statistical models and
sensitivity analyses.
This study was based on weight loss as a means to improve
pain and disability with implications for knee biomechanics
assuming that weight loss mainly works through mechanical
unloading of the knee13. Our results suggest that the primary ef-
fects of weight loss are not through mechanical unloading, but are
the result of interactive effects with other factors. It is important to
stress that these data do not imply weight loss as ineffective in
knee OA, because it has repeatedly been shown that weight loss
causes symptomatic relief14,20,51,52 with effect sizes comparable to
other interventions15. Furthermore, weight loss is generally asso-
ciated with desirable ‘side effects’ such as improved physical
performance53, and reductions in morbidity and mortality. Weight
loss should therefore be advocated in persons with obesity/over-
weight and knee OA.
Importantly, our results suggest that care must be taken when
developing a theoretical framework on which biomechanical in-
terventions in knee OA are considered. Our results indicate that
improvements in ambulatory knee function associated with
increased joint loads are safe in terms of detectable symptomatic
and structural progression of knee OA over 1 year in obese patients.
However, generalization to all types of OA interventions or for
longer term perspectives is premature.
In conclusion, our study showed that for obese patients with
knee OA, improving ambulation (by weight loss) with concomitant
increased knee joint loading (Loaders) produced no detectable
difference in the rate of symptomatic and structural disease pro-
gression over 1 year relative to a similar weight loss group (Un-
loaders) that had reduced ambulatory load.
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Cross-sectional data at week 0, 16 and 68 according to groups based on changes in join
Unloaders (n ¼ 100)
Week 0 Week 16
Mean (SD) Mean (SD)
Body mass, kg 102.3 (1.4) 87.7 (12.6)
BMI, kg/m2 36.9 (0.4) 31.7 (3.9)
Primary outcomes
Global max tibiofemoral cartilage loss, 0e3 2.0 (0.8) 2.0 (0.9)
KOOS4, 0e100 56.1 (1.3) 66.6 (16.4)
Secondary and explanatory outcomes
MRI
Medial max tibiofemoral cartilage loss, 0e3 1.9 (0.9) 1.8 (1.0)
Lateral max tibiofemoral cartilage loss, 0e3 1.4 (0.6) 1.3 (0.7)
Global max tibiofemoral BML, 0e3 1.7 (1.0) 1.5 (1.0)
Medial max tibiofemoral BML, 0e3 1.2 (1.1) 1.1 (1.0)
Lateral max tibiofemoral BML, 0e3 0.4 (0.8) 0.3 (0.6)
Patient reported
KOOS pain, 0e100 59.2 (1.5) 69.5 (18.4)
KOOS symptoms, 0e100 63.0 (1.6) 72.9 (18.2)
KOOS activities of daily living, 0e100 62.6 (1.5) 73.9 (17.3)
KOOS sports and recreation, 0e100 23.2 (2.0) 33.0 (26.4)
KOOS quality of life, 0e100 39.6 (1.5) 50.1 (19.0)
Walking biomechanics
Peak joint compression, N 2,886 (80.6) 2,378 (741)
Walking speed, m/s 1.20 (0.02) 1.21 (0.17)
Peak knee extensor moment, Nm 57.0 (2.9) 46.8 (23.7)
Peak knee ﬂexor moment, Nm 8.3 (2.2) 13.2 (17.0)
First peak knee abduction moment, Nm 48.6 (2.0) 43.0 (17.7)
Second peak knee abduction moment, Nm 44.5 (2.0) 40.0 (17.1)
First peak knee rotator moment, Nm 0.7 (0.1) 0.6 (1.0)
Second peak knee rotator moment, Nm 16.4 (0.7) 14.2 (5.5)
Objective physical function
6 MWD, m 448.6 (72.3) 485.6 (74.5)Robin Christensen. Conception, design, analysis and interpre-
tation, manuscript drafting, critical revision of the manuscript
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Loaders (n ¼ 57)
Week 68 Week 0 Week 16 Week 68
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
91.7 (15.7) 102.4 (1.9) 89.3 (14.3) 94.8 (15.3)
33.1 (5.0) 36.9 (0.6) 32.2 (4.3) 34.2 (5.0)
1.9 (0.9) 1.9 (0.9) 1.8 (0.9) 1.8 (0.9)
62.8 (17.2) 52.2 (2.0) 64.3 (17.1) 62.4 (17.5)
1.8 (1.0) 1.6 (1.1) 1.6 (1.0) 1.5 (1.1)
1.3 (0.7) 1.3 (0.6) 1.2 (0.6) 1.3 (0.6)
1.6 (1.0) 1.5 (1.0) 1.4 (0.9) 1.3 (0.8)
1.1 (1.0) 1.1 (1.1) 1.0 (0.9) 1.0 (1.0)
0.3 (0.6) 0.5 (0.8) 0.4 (0.6) 0.5 (0.7)
66.7(19.3) 56.0 (2.3) 68.7 (19.3) 67.0 (20.1)
68.0 (20.2) 58.1 (2.3) 69.1 (20.0) 67.6 (20.3)
70.7 (18.0) 57.9 (2.4) 72.4 (19.0) 68.8 (20.6)
29.6 (23.1) 20.4 (2.4) 31.8 (24.3) 28.7 (26.3)
45.8 (20.4) 36.6 (2.2) 47.0 (16.8) 46.1 (17.0)
2,728 (734) 2,222 (61.9) 2,647 (602) 2785 (702)
1.22 (0.16) 1.12 (0.02) 1.23 (0.20) 1.22 (0.18)
57.4 (21.7) 39.4 (2.0) 54.6 (18.0) 57.1 (21.8)
5.1 (15.2) 15.7 (2.0) 7.9 (16.5) 6.5 (17.0)
41.7 (16.0) 46.9 (2.4) 39.5 (15.7) 40.1 (14.6)
43.1 (20.1) 42.6 (2.6) 39.2 (16.8) 44.9 (16.0)
1.0 (1.5) 0.4 (0.1) 0.5 (1.0) 0.9 (1.1)
15.5 (6.1) 15.2 (0.8) 14.0 (5.7) 15.1 (5.5)
485.3 (84.1) 478.1 (74.6) 496.4 (70.6) 506.1 (85.3)
Appendix 2
Sensitivity analysis: changes in primary and secondary outcomes from week 16 to week 68 (i.e., after a 1-year maintenance period following a 16 week weight loss
intervention). Data are presented for patients grouped according to their changes in peak compression forces from week 16 to week 68. The ‘Unloaders16e68’ group
represents participants that during the 52 weeks decreased their peak compression force during walking. The ‘Loaders16e68’ group represents participants that during the
52 weeks increased their peak compression force during walking.
Least squares means (SE) Least squares
means difference (95% CI)
(Unloaders16e68eLoaders16e68)
P
Unloaders16e68 (n ¼ 45) Loaders16e68 (n ¼ 112)
Primary outcomes
DKOOS4, 0e100z 2.8 (1.9) 2.8 (1.4) 0.0 (4.2:4.2) 0.99
DGlobal max tibiofemoral cartilage loss, 0e3z 0.05 (0.07) 0.02 (0.05) 0.03 (0.13:0.19) 0.69
Secondary outcomesz
Demographics
DBody mass, kg 4.3 (1.1) 5.8 (0.9) 1.4 (3.8:0.9) 0.23
DBMI, kg/m2 1.3 (0.4) 1.9 (0.3) 0.5 (1.4:0.3) 0.23
Patient reported
DKOOS pain, 0e100 1.5 (2.3) 2.8 (1.7) 1.3 (3.7:6.4) 0.60
DKOOS symptoms, 0e100 0.8 (2.2) 3.1 (1.6) 2.3 (2.5:7.1) 0.35
DKOOS activities of daily living, 0e100 2.6 (2.2) 3.5 (1.6) 0.8 (4.0:5.7) 0.73
DKOOS sports and recreation, 0e100 7.9 (3.1) 4.3 (2.3) 3.6 (10.6:3.3) 0.31
DKOOS quality of life, 0e100 6.9 (2.5) 2.3 (1.8) 4.6 (10.1:0.8) 0.10
MRI
DMedial max tibiofemoral cartilage loss, 0e3 0.02 (0.07) 0.08 (0.05) 0.6 (0.10:0.21) 0.45
DLateral max tibiofemoral cartilage loss, 0e3 0.03 (0.06) 0.02 (0.05) 0.01 (0.13:0.15) 0.88
DGlobal max tibiofemoral BML, 0e3 0.18 (0.11) 0.06 (0.08) 0.12 (0.11:0.36) 0.31
DMedial max tibiofemoral BML, 0e3 0.03 (0.08) 0.03 (0.06) 0.0 (0.18:0.17) 0.96
DLateral max tibiofemoral BML, 0e3 0.01 (0.07) 0.02 (0.05) 0.0 (0.15:0.16) 0.93
Objective physical function
D6 MWD, m 2.4 (13.8) 6.5 (10.3) 4.1 (34.7:26.6) 0.79
Explanatory variablesz
Walking biomechanics
DPeak joint compression, N 322.5 (53.8) 519.7 (38.6) 842.1 (961.7:722.6) <0.0001
DWalking speed, m/s 0.07 (0.01) 0.03 (0.01) 0.10 (0.13:0.07) <0.0001
DPeak knee extensor moment, Nm 8.4 (1.9) 14.3 (1.4) 22.7 (27.0:18.4) <0.0001
DPeak knee ﬂexor moment, Nm 1.3 (2.0) 7.3 (1.5) 6.0 (10.4:1.6) 0.008
DFirst peak KAM, Nm 1.8 (1.3) 0.9 (1.0) 2.7 (0.2:5.6) 0.07
DSecond peak KAM, Nm 5.8 (1.3) 5.4 (1.0) 0.4 (2.4:3.1) 0.80
DFirst peak knee rotator moment, Nm 0.2 (0.2) 0.5 (0.1) 0.3 (0.1:0.7) 0.18
DSecond peak knee rotator moment, Nm 0.5 (0.5) 1.4 (0.3) 0.9 (1.9:0.1) 0.08
zAdjusted analysis: adjusted for baseline value, pre-weight loss (week 0) peak compression force, age, gender, week 16 BMI, and randomization in the underlying RCT.
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